Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-06
1997-05-06
Hollinden, Gary E.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
564253, 564268, 534 10, 534 14, 424 165, 424 153, 524 99, 524107, 548518, 548100, 546184, 544 63, 544 98, 544224, 544336, C07C24900, C07F 500, C07D23354, A61K 5104
Patent
active
056272863
ABSTRACT:
Novel compounds containing a heteroatom-bearing bridge and novel complexes of these compounds with metals. The novel compounds and complexes are useful in diagnostic and therapeutic methods.
REFERENCES:
patent: 3369121 (1968-02-01), Bruno et al.
patent: 3920995 (1975-11-01), Czaplinski et al.
patent: 4071613 (1978-01-01), Hunter, Jr.
patent: 4193979 (1980-03-01), Frank et al.
patent: 4272503 (1981-06-01), Camin et al.
patent: 4311689 (1982-01-01), Ruddock
patent: 4363793 (1982-12-01), Blau et al.
patent: 4431626 (1984-02-01), Henze
patent: 4444690 (1984-04-01), Fritzberg
patent: 4462992 (1984-07-01), Agrawal et al.
patent: 4615876 (1986-10-01), Troutner et al.
patent: 4638051 (1987-01-01), Burns et al.
patent: 4758682 (1988-07-01), Collins et al.
patent: 4789736 (1988-12-01), Canning et al.
patent: 4818813 (1989-04-01), Nowotnik et al.
patent: 4849511 (1989-07-01), Verbruggen
patent: 4871836 (1989-10-01), Francescono et al.
patent: 4880616 (1989-11-01), Azuma et al.
patent: 4895960 (1990-01-01), Deutsch
patent: 4925650 (1990-05-01), Nosco et al.
patent: 4980147 (1990-12-01), Fritzberg et al.
patent: 4986979 (1991-01-01), Morgan, Jr. et al.
patent: 4988496 (1991-01-01), Srinivasan et al.
patent: 5026829 (1991-06-01), Deutsch
patent: 5037631 (1991-08-01), Nosco
patent: 5071636 (1991-12-01), Yamauchi et al.
patent: 5075099 (1991-12-01), Srinivasan et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5091514 (1992-02-01), Fritzberg et al.
patent: 5096693 (1992-03-01), Azuma et al.
patent: 5101041 (1992-03-01), Troutner et al.
patent: 5104638 (1992-04-01), Nosco
patent: 5116596 (1992-05-01), Bremer et al.
patent: 5116598 (1992-05-01), Nosco
patent: 5164175 (1992-11-01), Bremer et al.
patent: 5164176 (1992-11-01), Gustavson et al.
patent: 5187264 (1993-02-01), Verbruggen
patent: 5302370 (1994-04-01), Neumeier et al.
patent: 5387692 (1995-02-01), Riley et al.
Elliott et al., "Synthesis of Potential Antiradiation Agents from 3-substituted 2-oxazolidinones derived from Phenol, Benzenethiol and Related Compounds", J. Med. Chem., vol. 12, No. 2, pp. 253-257, (1969).
Boschman et. al., "In vitro inhibition of ADP-induced patelet aggregation by O-(aminoalkyl) oxime ethers" Eur. J. Med. Chem.-Chem Therapeutica, Jul.-Aug. 1980, 15, No. 4 pp. 351-356. (1980).
Chapman, J.D., "Measurement of Tumor Hypoxia by Invasive and Non-Invasive Procedures: A Review of Recent Clinical Studies", Radiother. Oncol., 20, pp. 13-19 (1991).
Martin, G.V. et al., "Enhanced Binding of the Hypoxic Cell Marker [.sup.3 H]Fluoromisonidazole in Ischemic Myocardium", J. Nucl. Med., vol. 30, No. 2, 194-201 (1989).
Hoffman, J.M. et al., "Binding of the Hypoxia Tracer [.sup.3 H]Misonidazole in Cerebral Ischemia". Stroke, 18:168-176 (1987).
Koh, W.J. et al., "Hypoxia Imaging of Tumors Using [F-18] Fluoromisonidazole", J. Nucl. Med., 30,789 (No. 252) (1989).
Biskupiak, J.E. et al., "Synthesis of an (Iodovinyl)misonidazole Derivative for Hypoxia Imaging", J. Med. Chem., 34, pp. 2165-2168 (1991).
Chapman, J.D., "The Detection and Measurement of Hypoxic Cells in Solid Tumors", Cancer, Vo. 54, No. 11, pp. 2441-2449 (1984).
Kedderis, G.L. et al, "The Metabolic Activation of Nitroheterocyclic Therapeutic Agents", Drug Metabolism Reviews, 19(1), pp. 33-62 (1988).
Adams, G.E. et al., "Hypoxia-Mediated Nitro-Heterocyclic Drugs in The Radio-and Chemothrapy of Cancer", Biochemical Pharmacology, vol. 35, No. 1, pp. 71-76 (1986).
Brown, D.M. et al., "Structure-Activity Reationships of 1-Substituted 2-Nitroimidazoles: Effect of Partition Coefficient and Side-chain Hydroxyl Groups on Radiosensitization In Vitro", Radiation Research, 90, pp. 98-108 (1982).
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. I. Sensitization Efficiency", Int. J. Radiat. Biol., vol. 35, No. 2, pp. 133-150 (1979).
Adams, G.E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. III. Effects of Basic Substituents in Nitromidazole Sidechains", Int. J. Radiat. Biol., vol. 38, No. 6, pp. 613-626 (1980).
Jerabek, P.A., et al., "Synthesis and Biodistribution of .sup.18 F-Labeld Fluoronitroimidazoles: Potential In Vivo Markers of Hypoxic Tissue", Appl. Radiat. Isot. vol. 37, No. 7, pp. 599-605 (1986).
Martin, G.V. et al, "Fluoromisonidazole A Metabolic Marker of Myocyte Hypoxia", Circulation Research, 67, pp. 240-244 (1990).
Shelton, M.E. et al., "In Vivo Delineation of Myocardial Hypoxia During Coronary Occlusion Using Fluorin-18 Fluoromisonidazole and Positron Emission Tomography: A Potntial Approach for Idntification of Jeopardized Myocardium", J. Am. College Cardiology, vol. 16, No. 2, pp. 477-485 (Aug. 1990).
Mannan, R.H. et al., "Radioiodinated 1-(5-Iodo-5-deoxy-.beta.-D-arabinofuranosyl)-2-nitroimidazole (Iodazomycin Arabinoside: IAZA): A Novel Marker of Tissue Hypoxia", The Journal of Nuclear Medicine, vol. 32, No. 9, pp 1764-1770 (1991).
Parker, D., "Harnessing the Kinetic Stability of Macrocyclic Complexes In Vivo," presented at the 16th Int. Symp. on Macrocyclic Chemistry, Univ. of Sheffield, UK (Sep. 1-6, 1991).
Yang Kixi, et al., "Synthesis of Metronidazole Derivative and Its Distribution in Sarcoma 180 Bearing Mice", J. of Medical Colleges of PLA; 2(3) pp. 265-269 (1987).
Volkert, W.A. et al, ".sup.99m Tc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical", Eur. J. Nucl. Med., 9, pp. 511-516 (1984).
Kung, H.F., et al., "Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier", The Journal of Nuclear Medicine, 25, pp. 326-332 (1984).
Lever, S.Z. et al., "Design, Preparation, and Biodistribution of a Technetium-99m Triaminedithiol Complex to Assess Regional Cerebral Blood Flow", J. Nucl. Med., 26, pp. 1287-1294 (1985).
Jurisson et al., "Synthesis, Characterization, and X-ray Structural Determination of Technetium (V)-Oxo-Tetradentate Amine Oxime Complexes", Inorg. Chm., 25, pp. 543-549 (1986).
Ding et al., "Review and Prospectives of Brain Radioppharmaceuticals", Nucl. Sci. J., 29(5), pp. 341-348 (1992).
Fattorusso et al., J. Chem. Soc., Daltons Trans., p. 752 (1970).
Moody et al., J. Chem. Soc. Perkin Trans. 1, (1), pp. 18-24 (1972).
Svetkin et al., Zh. Obshch Khim, 41(11), pp. 2553-2555 (1971).
Hook et al., Anti-Cancer Drug Res., 4(3), pp. 173-190 (1989).
Curtius, Hechtenberg, J. Pract. Chem., 105, 314 (1922).
Orna et al., "Correlation of Kinetic Parameters of Nitroreductase Enzymes with Redox Properties of Nitroaromatic Compounds", J. Biol. Chem., vol. 264, 21, pp. 12379-12384 (1989).
Murmann, K., "The Interaction of 2-Methyl-2-amino-3-butanone Oxime with Nickel (II) and Copper (II) Ions", J. Am. Chem. Soc., pp. 4174-4180 (1958).
Vassian et al., "Aromatization of an Aliphatic Amine Oxime Nickel (II) Complex by Molecular Oxygen", Inorg. Chemistry, vol. 6, No. 11, pp. 2043-2046 (1967).
Murmann et al., "An Unsymmetrical transDinitrocobalt (III) Complex. A Crystal Structure Determination", Inorg. Chem., vol. 12, No. 11, pp. 2625-2631 (1973).
Somin et al. "Oximes of w-dimethylaminoalkanals and their derivatives." Zh. Organ. Khim. vol. 1 (II), pp. 1973-1976, (1965) (Russian) [Chem Abs.] vol. 64, p. 9582(f).
Corbin, et. al. "Substituted Cysteame Ligands and Their Complexes with Molybdenum(VI)", Inorg. Chem. vol. 23, pp. 3404-4312, (1984).
Bryson, et. al. "Neutral Technitium(V) Complexes with Amide-Thiol-Thioether Chelating Ligands" Inor. Chem. vol. 27, pp. 2154-2161, (1988).
Panakaskie et. al., Synthetic Communications, vol. 19, pp. 339-344 (1966).
Biniakiewicz et. al. "A New, General synthetic Route to Multidentate N,S Ligands for Use in Technetium-99m Radiopharmaceuticals." J. Med. Chem., vol. 35, pp. 274-279, (1992).
Raju Natarajan
Ramalingam Kondareddiar
Bracco International B.V.
Hartley Michael G.
Hoare George P.
Hollinden Gary E.
Rhoads Donald L.
LandOfFree
Heteroatom-bearing ligands and metal complexes thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heteroatom-bearing ligands and metal complexes thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroatom-bearing ligands and metal complexes thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2133740